Thyreotrop hormont szekretáló hypophysis adenomák diagnosztikája és kezelése öt eset kapcsán.

Translated title of the contribution: Thyrotropin-secreting pituitary adenomas--diagnosis and treatment in five case

I. Szabolcs, S. Czirják, Erika Hubina, M. Góth, Mihály Tarkó, Barna Bakó, András Konrády, József Pátkay, László Kovács, Zoltán Görömbey, Andrea Radácsi, G. Kovács, G. Szilágyi

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

The authors report five cases of thyrotropin secreting pituitary adenomas (4 males and 1 female) in whom the diagnosis was established by a combined occurrence of elevated serum free thyroid hormone levels and measurable serum thyrotropin concentration, as well as by visualisation of the pituitary adenomas using magnetic resonance imaging (pituitary microadenoma in two and macroadenoma in three cases). Other tests were less diagnostic: only two out of 4 patients proved to be non-responders during testing with thyrotropin releasing hormone, and serum alpha subunit was elevated in only 2 out of 3 cases. There was a significant decrease of serum thyrotropin concentration in all of the four patients tested by 100 micrograms octreotide (Sandostatin, Novartis). Somatostatin-analogue treatment (slow release preparation in two cases) restored euthyroidism in all three cases treated prior to surgery. In one case the hyperthyroidism persisted after surgery of the macroadenoma, but irradiation of the pituitary area and subsequent somatostatin-analogue treatment resulted finally in a complete cure (euthyroidism and no tumor remnant). In the three other operated patients surgery resulted in euthyroidism. These cases demonstrate the variety of diagnostic and therapeutical modalities in the management of thyrotropin secreting pituitary adenomas.

Original languageHungarian
Pages (from-to)1074-1077
Number of pages4
JournalOrvosi Hetilap
Volume143
Issue number19 Suppl
Publication statusPublished - May 12 2002

Fingerprint

Pituitary Neoplasms
Thyrotropin
Octreotide
Somatostatin
Serum
Pituitary Irradiation
Thyrotropin-Releasing Hormone
Hyperthyroidism
Therapeutics
Thyroid Hormones
Magnetic Resonance Imaging
Neoplasms

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Thyreotrop hormont szekretáló hypophysis adenomák diagnosztikája és kezelése öt eset kapcsán. / Szabolcs, I.; Czirják, S.; Hubina, Erika; Góth, M.; Tarkó, Mihály; Bakó, Barna; Konrády, András; Pátkay, József; Kovács, László; Görömbey, Zoltán; Radácsi, Andrea; Kovács, G.; Szilágyi, G.

In: Orvosi Hetilap, Vol. 143, No. 19 Suppl, 12.05.2002, p. 1074-1077.

Research output: Contribution to journalArticle

Szabolcs, I, Czirják, S, Hubina, E, Góth, M, Tarkó, M, Bakó, B, Konrády, A, Pátkay, J, Kovács, L, Görömbey, Z, Radácsi, A, Kovács, G & Szilágyi, G 2002, 'Thyreotrop hormont szekretáló hypophysis adenomák diagnosztikája és kezelése öt eset kapcsán.', Orvosi Hetilap, vol. 143, no. 19 Suppl, pp. 1074-1077.
Szabolcs, I. ; Czirják, S. ; Hubina, Erika ; Góth, M. ; Tarkó, Mihály ; Bakó, Barna ; Konrády, András ; Pátkay, József ; Kovács, László ; Görömbey, Zoltán ; Radácsi, Andrea ; Kovács, G. ; Szilágyi, G. / Thyreotrop hormont szekretáló hypophysis adenomák diagnosztikája és kezelése öt eset kapcsán. In: Orvosi Hetilap. 2002 ; Vol. 143, No. 19 Suppl. pp. 1074-1077.
@article{6e2afc0259274ddb9a5ebb236533f34b,
title = "Thyreotrop hormont szekret{\'a}l{\'o} hypophysis adenom{\'a}k diagnosztik{\'a}ja {\'e}s kezel{\'e}se {\"o}t eset kapcs{\'a}n.",
abstract = "The authors report five cases of thyrotropin secreting pituitary adenomas (4 males and 1 female) in whom the diagnosis was established by a combined occurrence of elevated serum free thyroid hormone levels and measurable serum thyrotropin concentration, as well as by visualisation of the pituitary adenomas using magnetic resonance imaging (pituitary microadenoma in two and macroadenoma in three cases). Other tests were less diagnostic: only two out of 4 patients proved to be non-responders during testing with thyrotropin releasing hormone, and serum alpha subunit was elevated in only 2 out of 3 cases. There was a significant decrease of serum thyrotropin concentration in all of the four patients tested by 100 micrograms octreotide (Sandostatin, Novartis). Somatostatin-analogue treatment (slow release preparation in two cases) restored euthyroidism in all three cases treated prior to surgery. In one case the hyperthyroidism persisted after surgery of the macroadenoma, but irradiation of the pituitary area and subsequent somatostatin-analogue treatment resulted finally in a complete cure (euthyroidism and no tumor remnant). In the three other operated patients surgery resulted in euthyroidism. These cases demonstrate the variety of diagnostic and therapeutical modalities in the management of thyrotropin secreting pituitary adenomas.",
author = "I. Szabolcs and S. Czirj{\'a}k and Erika Hubina and M. G{\'o}th and Mih{\'a}ly Tark{\'o} and Barna Bak{\'o} and Andr{\'a}s Konr{\'a}dy and J{\'o}zsef P{\'a}tkay and L{\'a}szl{\'o} Kov{\'a}cs and Zolt{\'a}n G{\"o}r{\"o}mbey and Andrea Rad{\'a}csi and G. Kov{\'a}cs and G. Szil{\'a}gyi",
year = "2002",
month = "5",
day = "12",
language = "Hungarian",
volume = "143",
pages = "1074--1077",
journal = "Orvosi Hetilap",
issn = "0030-6002",
publisher = "Akademiai Kiado",
number = "19 Suppl",

}

TY - JOUR

T1 - Thyreotrop hormont szekretáló hypophysis adenomák diagnosztikája és kezelése öt eset kapcsán.

AU - Szabolcs, I.

AU - Czirják, S.

AU - Hubina, Erika

AU - Góth, M.

AU - Tarkó, Mihály

AU - Bakó, Barna

AU - Konrády, András

AU - Pátkay, József

AU - Kovács, László

AU - Görömbey, Zoltán

AU - Radácsi, Andrea

AU - Kovács, G.

AU - Szilágyi, G.

PY - 2002/5/12

Y1 - 2002/5/12

N2 - The authors report five cases of thyrotropin secreting pituitary adenomas (4 males and 1 female) in whom the diagnosis was established by a combined occurrence of elevated serum free thyroid hormone levels and measurable serum thyrotropin concentration, as well as by visualisation of the pituitary adenomas using magnetic resonance imaging (pituitary microadenoma in two and macroadenoma in three cases). Other tests were less diagnostic: only two out of 4 patients proved to be non-responders during testing with thyrotropin releasing hormone, and serum alpha subunit was elevated in only 2 out of 3 cases. There was a significant decrease of serum thyrotropin concentration in all of the four patients tested by 100 micrograms octreotide (Sandostatin, Novartis). Somatostatin-analogue treatment (slow release preparation in two cases) restored euthyroidism in all three cases treated prior to surgery. In one case the hyperthyroidism persisted after surgery of the macroadenoma, but irradiation of the pituitary area and subsequent somatostatin-analogue treatment resulted finally in a complete cure (euthyroidism and no tumor remnant). In the three other operated patients surgery resulted in euthyroidism. These cases demonstrate the variety of diagnostic and therapeutical modalities in the management of thyrotropin secreting pituitary adenomas.

AB - The authors report five cases of thyrotropin secreting pituitary adenomas (4 males and 1 female) in whom the diagnosis was established by a combined occurrence of elevated serum free thyroid hormone levels and measurable serum thyrotropin concentration, as well as by visualisation of the pituitary adenomas using magnetic resonance imaging (pituitary microadenoma in two and macroadenoma in three cases). Other tests were less diagnostic: only two out of 4 patients proved to be non-responders during testing with thyrotropin releasing hormone, and serum alpha subunit was elevated in only 2 out of 3 cases. There was a significant decrease of serum thyrotropin concentration in all of the four patients tested by 100 micrograms octreotide (Sandostatin, Novartis). Somatostatin-analogue treatment (slow release preparation in two cases) restored euthyroidism in all three cases treated prior to surgery. In one case the hyperthyroidism persisted after surgery of the macroadenoma, but irradiation of the pituitary area and subsequent somatostatin-analogue treatment resulted finally in a complete cure (euthyroidism and no tumor remnant). In the three other operated patients surgery resulted in euthyroidism. These cases demonstrate the variety of diagnostic and therapeutical modalities in the management of thyrotropin secreting pituitary adenomas.

UR - http://www.scopus.com/inward/record.url?scp=0037066892&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037066892&partnerID=8YFLogxK

M3 - Article

C2 - 12063864

AN - SCOPUS:0037066892

VL - 143

SP - 1074

EP - 1077

JO - Orvosi Hetilap

JF - Orvosi Hetilap

SN - 0030-6002

IS - 19 Suppl

ER -